FSU-Orlando

Objectives - At the end of the educational activity, participants should: Be able to identify Highly Effective Modulator Therapy (HEMT) for Cystic Fibrosis (CF) patients Be able to understand the newborn screening process for CF in Florida and interpret the result for patients with disease versus gene carrier Be able to explain to parents the excellent prognosis for CF patients and know when to refer a patient to a CF Specialty Care center